Q1 2025 Pharmacy Utilization management Update
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 911 - 920 ntawm 4139
Tus kws kho mob
QP79-24 Commercial Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective January 1, 2025
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 13, 2024
Tus kws kho mob
QP81-24 Health Equity Certification 2025 Launch
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 13, 2024
Tus kws kho mob
QP78-24 MHCP Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective December 1, 2024
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 13, 2024
Tus kws kho mob
QP84-24 Commercial Pharmacy Benefit Exclusion for Tremfya® and Ocrevus Zunovo™
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 13, 2024
Tus kws kho mob
QP83-24 MHCP Pharmacy Benefit Exclusion for Tremfya®, Tecentriq Hybreza™ and Ocrevus Zunovo™
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 13, 2024
Tus kws kho mob
QP82-24 Enhanced Authorization Submissions through Availity Essentials
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 13, 2024
Tus kws kho mob
QP80-24 Commercial Pharmacy Benefit Exclusion for Select Medications
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 13, 2024